• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears Zeiss bipolar forceps for electrosurgery

FDA clears Zeiss bipolar forceps for electrosurgery

October 11, 2022 By Sean Whooley

Zeiss Medical MTLawton
The MTLawton device. [Image from Zeiss]
Zeiss Medical Technology announced that it received FDA 510(k) clearance for its MTLawton disposable bipolar forceps.

Jena, Germany-based Zeiss designed the forceps with a special copper-base alloy. MTLawton potentially reduces tissue adhesion and subsequent charring during the dissection of tissue.

The system also features an extended shaft that helps the forceps reduce visual restrictions in the surgical field. This helps surgeons with efficiency during electrosurgical procedures. MTLawton came out of a close collaboration with neurosurgeon Dr. Michael T. Lawton, according to a news release.

“The MTLawton Disposable Bipolar Forceps are a real advance in electrosurgery over aluminum forceps. Our copper-base alloy has superior thermal conduction to improve cautery-based hemostasis and reduce tissue adhesion,” said Lawton, president and CEO of the Barrow Neurological Institute in Phoenix and chair of its Department of Neurosurgery.

Added Lawton: “I take these MTLawton bipolars into battle with all my difficult arteriovenous malformations, and they give me a noticeable advantage.”

According to Zeiss, high heat can cause electrosurgical instruments to stick to the tissue when coagulating it. MT Lawton enables non-stick technology through the copper-base alloy. The improved material conducts heat away from the silver-plated tips faster. This potentially reduces tissue adhesion and charring.

MTLawton also allows for a clear view of the cauterization area, even in narrow and deep cavities. The robust copper-based materials also allow for the more efficient handling of tissue, Ziess says.

“With the acquisition of Kogent Surgical in April 2022, ZEISS has expanded its range of surgical solutions for microsurgery. We are pleased to be able to introduce the first surgical instrument from this acquisition to the market with FDA approval for MTLawton,” said Dr. Markus Weber, CEO of Carl Zeiss Meditec.

Filed Under: 510(k), Food & Drug Administration (FDA), News Well, Regulatory/Compliance, Surgical Tagged With: Carl Zeiss Meditec, FDA

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy